| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4bd97b9fd81d7ab9674cce4370342e28 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04 |
| filingDate |
2013-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c2ea4211dc1795f59d697664124f894
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cf6766493d9089db8712a13eb7ab381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d827d292e6db38fb0b8f9ae873a2628 |
| publicationDate |
2013-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2013211445-A1 |
| titleOfInvention |
Pharmaceutical Compositions |
| abstract |
Abstract Provided herein is a method of treating a condition in a host that is responsive to an agonist, the method comprising administering to the host a multi-layer pharmaceutical composition comprising the agonist eg. an opioid and an antagonist eg. naltrexone thereof, wherein the agonist and antagonist are not in direct contact with one another in the intact form of the composition. |
| priorityDate |
2006-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |